24 October, 2024

Navigating the Latest Revisions in GVP: Key Updates on Module XVI and Risk Minimization Measures

Insights Hub

In today’s evolving regulatory landscape, staying abreast of updates to Good Pharmacovigilance Practices (GVP) is crucial for maintaining drug safety and compliance. This essential webinar focuses on the latest revisions to GVP Module XVI, highlighting Risk Minimization Measures (aRMMs).

Led by distinguished pharmacovigilance professionals Elena Alcaraz Garcia, EU & UK QPPV and Strategic Advisor, and Mercedina del Papa, EU & UK QPPV and Strategic Advisor at PrimeVigilance, this webinar equips Marketing Authorization Holders and applicants with actionable insights for navigating the updated regulatory requirements. Gain an insider’s perspective on implementing effective risk minimization strategies to enhance patient safety and regulatory compliance.

Key Takeaways Include:

In-depth analysis of recent updates to GVP Module XVI and Addendum II
Best practices for developing and implementing risk minimization measures
Techniques for evaluating the impact of risk minimization on medicinal products
Strategies to maintain a favorable risk-benefit balance throughout the product lifecycle

Watch the recording now to strengthen your pharmacovigilance strategy and keep pace with evolving GVP requirements.

Submit form to access content.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Job Title

Industry*

Company*

Business Email*

Phone

Country*

State*

By submitting this form, you consent to your personal data being processed in alignment with our privacy policy. Your personal data will be processed for purpose of facilitating your request and may be used for sending you additional marketing and business development-related information about PrimeVigilance, its affiliates and our services. You can withdraw your consent at any time at marketing@ergomedgroup.com, and your personal data will be erased. For more information about our privacy policy and your privacy rights, please visit our website’s data policy section.